Calabar Capital

The greatest gap in healthcare is also its greatest opportunity

Sex-specific medicine is producing clinical and commercial data that is changing how regulators, payers, and acquirers behave.

• READ OUR INSIGHTS

What We Do

Calabar Capital was founded to help sophisticated investors access this thesis with institutional rigour through a strategy built on long-duration conviction, precision medicine fundamentals, and the structural shifts already shaping capital flows in this category.Our work sits at the intersection of strategic advisory, thematic research, and healthcare market insight, supported by institutional capital markets experience and a growing network across healthcare, science, and investment.

Our Approach

We work with a select group of clients who share a common view: that many of healthcare’s largest inefficiencies are also emerging investment opportunities.Our approach combines institutional investment experience with differentiated market insight, long-term thematic thinking, and deep engagement across the evolving healthcare ecosystem.We believe the next generation of healthcare value creation will come from identifying structural shifts early before they become consensus.

• start a conversation

Who We Are

Maryann Selfe is the founder of Calabar Capital and she has twenty-five years' experience in institutional capital markets. Former Head of Investment Solutions at BIL Suisse with prior experience at Credit Suisse (Later UBS) advising family offices and institutional clients on capital allocation across public and private markets. Maryann is a healthcare investor and author of the book, The Billion Dollar Blindspot.

• learn more

Get in Touch

If you are a sophisticated investor and this thesis resonates, we would like to hear from you.